Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Limited U.S./China export agreement

This article was originally published in The Gray Sheet

Executive Summary

Pact inked Dec. 11 between HHS and China's State Food and Drug Administration to enhance the safety of devices and drugs exported to the U.S. from China will cover exports of glucose test strips and condoms. The agreement will require all Chinese producers of the devices to register with the Chinese government and develop and implement a program to certify that the products meet FDA safety standards. The two countries also agreed to notify each other within 24 hours if the devices cause serious adverse health consequences and to exchange lists of registered firms that manufacture the devices. Some in Congress are already critiquing the agreement, saying that the limited list of products it covers falls short of what is needed to protect American consumers from unsafe Chinese imports. The agreement "doesn't cover nearly enough products to restore our confidence in Chinese goods," said Sen. Dick Durbin, D-Ill

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025600

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel